|
Volumn 104, Issue 20, 2007, Pages 8205-8206
|
Subtype-selective sodium channel blockers promise a new era of pain research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
A 803467;
PROSTAGLANDIN DERIVATIVE;
SODIUM CHANNEL;
SODIUM CHANNEL BLOCKING AGENT;
TETRODOTOXIN;
UNCLASSIFIED DRUG;
ANALGESIC AGENT;
NA(V)1.8 PROTEIN, RAT;
NERVE PROTEIN;
SENSORY NEURON SPECIFIC (SNS) SODIUM CHANNEL;
CHRONIC PAIN;
DRUG RESEARCH;
HUMAN;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
ANIMAL;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
DRUG ANTAGONISM;
INFLAMMATION;
MALE;
METABOLISM;
MONONEUROPATHY;
PAIN;
PATHOLOGY;
RAT;
ANALGESICS;
ANIMALS;
HUMANS;
INFLAMMATION;
MALE;
MONONEUROPATHIES;
NERVE TISSUE PROTEINS;
PAIN;
RATS;
SODIUM CHANNEL BLOCKERS;
SODIUM CHANNELS;
|
EID: 34347226327
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.0703091104 Document Type: Note |
Times cited : (16)
|
References (11)
|